ストックスクリーナーアプリを入手
341.78
1.14%
3.84
前日終値:
$337.94
開ける：
$337.75
24時間の取引高:
472.87K
Relative Volume:
0.70
時価総額：
$24.06B
収益：
$2.36B
当期純損益:
$236.10M
株価収益率:
103.88
EPS:
3.29
ネットキャッシュフロー:
$382.50M
1週間 パフォーマンス:
-1.91%
1か月 パフォーマンス:
+10.38%
6か月 パフォーマンス:
+37.60%
1年 パフォーマンス:
+48.31%
1日の値動き範囲:
$336.00
$351.94
1週間の範囲:
$330.00
$353.50
52週間の値動き範囲:
$225.37
$353.50
Insulet Corporation Stock (PODD) Company Profile
PODD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
341.78 | 23.77B | 2.36B | 236.10M | 382.50M | 3.29 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-08 | 再開されました | Oppenheimer | Outperform |
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-05-30 | 開始されました | Goldman | Buy |
| 2025-05-13 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-07 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-21 | アップグレード | Citigroup | Neutral → Buy |
| 2023-08-21 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-04 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-07-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-03 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-02-02 | アップグレード | UBS | Neutral → Buy |
| 2022-01-31 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-01 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-07-28 | 開始されました | Wells Fargo | Overweight |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 開始されました | BofA/Merrill | Neutral |
| 2020-03-31 | ダウングレード | Berenberg | Buy → Hold |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-12-10 | 開始されました | CFRA | Sell |
| 2019-10-23 | 開始されました | Stifel | Hold |
| 2019-10-18 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | ダウングレード | BTIG Research | Buy → Neutral |
| 2019-10-04 | ダウングレード | UBS | Buy → Neutral |
| 2019-10-03 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-08-06 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-06-10 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | アップグレード | BTIG Research | Neutral → Buy |
| 2018-04-20 | 開始されました | Berenberg | Buy |
| 2018-02-22 | 繰り返されました | Barclays | Overweight |
| 2018-01-08 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 開始されました | Barclays | Overweight |
すべてを表示
Insulet Corporation (PODD) 最新ニュース
Insulet (NASDAQ:PODD) Hits New 12-Month High on Analyst Upgrade - MarketBeat
Vident Advisory LLC Purchases Shares of 822 Insulet Corporation $PODD - MarketBeat
Vancity Investment Management Ltd Purchases New Stake in Insulet Corporation $PODD - MarketBeat
Oppenheimer Forecasts Strong Price Appreciation for Insulet (NASDAQ:PODD) Stock - MarketBeat
AQR Capital Management LLC Sells 16,546 Shares of Insulet Corporation $PODD - MarketBeat
Insulet (NASDAQ:PODD) Stock Price Down 5% After Insider Selling - MarketBeat
Why Insulet (PODD) is a Top Growth Stock for the Long-Term - Yahoo Finance
Geneos Wealth Management Inc. Increases Position in Insulet Corporation $PODD - MarketBeat
JPMorgan Adjusts Price Target on Insulet to $415 From $340, Maintains Overweight Rating - MarketScreener
Fred Alger Management LLC Lowers Stock Holdings in Insulet Corporation $PODD - MarketBeat
Alliancebernstein L.P. Raises Stock Holdings in Insulet Corporation $PODD - MarketBeat
Jacobs Levy Equity Management Inc. Makes New $24.48 Million Investment in Insulet Corporation $PODD - MarketBeat
Insider Selling: Insulet (NASDAQ:PODD) SVP Sells 687 Shares of Stock - MarketBeat
Insulet Corporation $PODD Shares Sold by Meiji Yasuda Asset Management Co Ltd. - MarketBeat
MBB Public Markets I LLC Invests $322,000 in Insulet Corporation $PODD - MarketBeat
Parkman Healthcare Partners LLC Has $34.27 Million Stake in Insulet Corporation $PODD - MarketBeat
3 Reasons Investors Love Insulet (PODD) - Yahoo Finance
Insulet Corporation $PODD Shares Sold by Polar Asset Management Partners Inc. - MarketBeat
ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know - Yahoo Finance
Insulet Corporation $PODD Shares Acquired by Hawk Ridge Capital Management LP - MarketBeat
EFG Asset Management North America Corp. Trims Stock Position in Insulet Corporation $PODD - MarketBeat
Top Executives at Insulet Make Significant Stock Sales! - TipRanks
Canada Pension Plan Investment Board Lowers Position in Insulet Corporation $PODD - MarketBeat
Insulin pump makers Tandem and Insulet post contrasting Q2 results - MSN
Insulet at Baird Global Healthcare: Strategic Growth and Innovation By Investing.com - Investing.com South Africa
Insulet at Baird Global Healthcare: Strategic Growth and Innovation - Investing.com
Transcript : Insulet Corporation Presents at Baird Global Healthcare Conference 2025, Sep-09-2025 12 - MarketScreener
Insulet stock hits all-time high at 350.92 USD - Investing.com
Insulet Stock: Analyst Estimates & Ratings - MSN
US medical device maker plans Middle East expansion - Arabian Gulf Business Insight | AGBI
Oppenheimer Adjusts Insulet Price Target to $365 From $324, Maintains Outperform Rating - MarketScreener
Oppenheimer initiates coverage on Insulet stock with Outperform rating By Investing.com - Investing.com South Africa
Oppenheimer initiates coverage on Insulet stock with Outperform rating - Investing.com
Oppenheimer Starts Insulet Corporation (PODD) at Outperform - StreetInsider
Adage Capital Partners GP L.L.C. Purchases 92,136 Shares of Insulet Corporation $PODD - MarketBeat
First Light Asset Management LLC Has $4.47 Million Position in Insulet Corporation $PODD - MarketBeat
Redmile Group LLC Purchases 17,550 Shares of Insulet Corporation $PODD - MarketBeat
What’s Insulet Corporation’s historical returnMarket Weekly Review & Daily Profit Maximizing Trade Tips - خودرو بانک
Market Participants Recognise Insulet Corporation's (NASDAQ:PODD) Revenues Pushing Shares 26% Higher - simplywall.st
Can Insulet Corporation keep up with sector leadersWeekly Stock Recap & Weekly High Return Stock Opportunities - خودرو بانک
Insulet Corporation $PODD Shares Bought by Panagora Asset Management Inc. - MarketBeat
Is Insulet Corporation subject to activist investor interest2025 Volatility Report & Fast Moving Trade Plans - خودرو بانک
Short interest data insights for Insulet CorporationTake Profit & Technical Pattern Based Buy Signals - Newser
Can Insulet Corporation stock outperform in a bear marketLayoff News & Community Consensus Trade Alerts - خودرو بانک
Is Insulet Corporation a top pick in the sectorQuarterly Trade Summary & Free Growth Oriented Trading Recommendations - خودرو بانک
What is the long term forecast for Insulet Corporation stockMarket Activity Report & Safe Entry Zone Identification - خودرو بانک
What high frequency data says about Insulet CorporationBond Market & Long Hold Capital Preservation Tips - Newser
Candlestick signals on Insulet Corporation stock today2025 Price Targets & High Return Stock Watch Alerts - Newser
Insulet Corporation (PODD) 財務データ
収益
当期純利益
現金流量
EPS
1.01%
0.29%
大文字化:
|
ボリューム (24 時間):